PE20191491A1 - QUICK RELEASE COMPOSITION OF CINITAPRIDE AND SYMETICONE AND PROCESS TO PREPARE IT - Google Patents
QUICK RELEASE COMPOSITION OF CINITAPRIDE AND SYMETICONE AND PROCESS TO PREPARE ITInfo
- Publication number
- PE20191491A1 PE20191491A1 PE2019001412A PE2019001412A PE20191491A1 PE 20191491 A1 PE20191491 A1 PE 20191491A1 PE 2019001412 A PE2019001412 A PE 2019001412A PE 2019001412 A PE2019001412 A PE 2019001412A PE 20191491 A1 PE20191491 A1 PE 20191491A1
- Authority
- PE
- Peru
- Prior art keywords
- cinitapride
- symeticone
- prepare
- quick release
- release composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invencion se refiere a una composicion farmaceutica de administracion oral, bajo la forma de capsulas con contenido liquido, que comprende una combinacion a dosis fija de Cinitaprida tartrato y Simeticona junto con al menos un agente surfactante y opcionalmente uno o mas excipientes farmaceuticamente aceptables, y el proceso para obtener dicha composicion.The present invention relates to a pharmaceutical composition for oral administration, in the form of capsules with liquid content, which comprises a combination at a fixed dose of Cinitapride tartrate and Simethicone together with at least one surfactant agent and optionally one or more pharmaceutically acceptable excipients, and the process for obtaining said composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2017001714A MX2017001714A (en) | 2017-02-07 | 2017-02-07 | Rapid-release composition of cinitapride and simeticone and method for preparing same. |
PCT/IB2018/050528 WO2018146575A1 (en) | 2017-02-07 | 2018-01-29 | Rapid-release composition of cinitapride and simeticone and method for preparing same |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20191491A1 true PE20191491A1 (en) | 2019-10-21 |
Family
ID=63108046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2019001412A PE20191491A1 (en) | 2017-02-07 | 2018-01-29 | QUICK RELEASE COMPOSITION OF CINITAPRIDE AND SYMETICONE AND PROCESS TO PREPARE IT |
Country Status (10)
Country | Link |
---|---|
AR (1) | AR110797A1 (en) |
BR (1) | BR112019015989A2 (en) |
CL (1) | CL2019001944A1 (en) |
CO (1) | CO2019008347A2 (en) |
CR (1) | CR20190402A (en) |
DO (1) | DOP2019000190A (en) |
EC (1) | ECSP19051198A (en) |
MX (1) | MX2017001714A (en) |
PE (1) | PE20191491A1 (en) |
WO (1) | WO2018146575A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6676933B2 (en) * | 2001-05-23 | 2004-01-13 | Osmotica Corp. | Pharmaceutical composition containing mosapride and pancreatin |
WO2004071374A2 (en) * | 2003-02-11 | 2004-08-26 | Torrent Pharmaceuticals Limited | Once a day orally administered pharmaceutical compositions |
CN101065115A (en) * | 2004-11-24 | 2007-10-31 | 默克公司 | Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide |
WO2009066146A2 (en) * | 2007-11-19 | 2009-05-28 | Cadila Pharmaceuticals Ltd. | Stable solutions of sparingly soluble actives |
-
2017
- 2017-02-07 MX MX2017001714A patent/MX2017001714A/en unknown
-
2018
- 2018-01-29 WO PCT/IB2018/050528 patent/WO2018146575A1/en active Application Filing
- 2018-01-29 BR BR112019015989-4A patent/BR112019015989A2/en active Search and Examination
- 2018-01-29 CR CR20190402A patent/CR20190402A/en unknown
- 2018-01-29 PE PE2019001412A patent/PE20191491A1/en unknown
- 2018-02-06 AR ARP180100282A patent/AR110797A1/en unknown
-
2019
- 2019-07-11 CL CL2019001944A patent/CL2019001944A1/en unknown
- 2019-07-16 EC ECSENADI201951198A patent/ECSP19051198A/en unknown
- 2019-07-19 DO DO2019000190A patent/DOP2019000190A/en unknown
- 2019-07-30 CO CONC2019/0008347A patent/CO2019008347A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112019015989A2 (en) | 2020-03-31 |
DOP2019000190A (en) | 2019-10-15 |
ECSP19051198A (en) | 2019-07-31 |
MX2017001714A (en) | 2018-08-06 |
CO2019008347A2 (en) | 2019-08-30 |
AR110797A1 (en) | 2019-05-02 |
WO2018146575A1 (en) | 2018-08-16 |
CL2019001944A1 (en) | 2019-12-06 |
CR20190402A (en) | 2019-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2018000297A (en) | DERIVATIVE OF GLUCAGON, CONJUGATE OF THE SAME, COMPOSITION THAT INCLUDES THE SAME AND THERAPEUTIC USE OF THE SAME | |
CL2015003072A1 (en) | Long-term colchicine release formulations and methods of use thereof. | |
CL2018002727A1 (en) | Medicine obtained by combining agonist fxr and arb | |
ECSP16084317A (en) | PHARMACEUTICAL FORMULATIONS, PREPARATION PROCESSES AND METHODS OF USE | |
MX2018002461A (en) | Pharmaceutical composition used for reducing localised fat and use of pharmaceutical composition. | |
CL2019002218A1 (en) | Triple combination formulations and methods to treat or reduce the risk of cardiovascular disease. | |
CL2016002560A1 (en) | Oral solid pharmaceutical dosage form comprising siponimod, a moisture protective agent and optionally a pharmaceutical excipient; Preparation procedure | |
BR112018015367A2 (en) | nanofiber oromucosal carriers for therapeutic treatment | |
CO2019002245A2 (en) | Fxr agonist combination | |
CL2018003682A1 (en) | Oral pharmaceutical composition, comprising a pharmaceutically active agent, at least one bioadhesive cationic polymer and at least two anionic polymers. | |
PH12018502524A1 (en) | Physiologically balanced injectable formulations of fosnetupitant | |
MX2015003956A (en) | Pharmaceutical composition comprising micronized pinaverium bromide and simeticone. | |
PE20191491A1 (en) | QUICK RELEASE COMPOSITION OF CINITAPRIDE AND SYMETICONE AND PROCESS TO PREPARE IT | |
PE20160245A1 (en) | STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A DISPERSABLE TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS | |
ECSP16005208A (en) | STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS | |
CR20170125A (en) | SOLID PHARMACEUTICAL COMPOSITION INCLUDING AMLODIPINA AND LOSARTÁN | |
AR099330A1 (en) | USE OF PARICALCITOL IN THE TREATMENT OF INFLAMMATORY ANEMIA | |
CO2019006693A2 (en) | Improved composition of lansoprazole and simethicone and process to prepare it | |
CR20190401A (en) | Dropropizine in combination with ambroxol in the dosage form of syrup or tablets | |
IN2013MU02015A (en) | ||
AR114006A1 (en) | PHARMACEUTICAL COMBINATION IN THE FORM OF TWO-LAYER TABLETS THAT INCLUDE KETOROLACO TROMETAMINE AND TRAMADOL HYDROCHLORIDE, AND ITS USE FOR THE TREATMENT OF PAIN | |
ECSP19044926A (en) | IMPROVED COMPOSITION OF LANSOPRAZOLE AND SYMETICONE AND PROCESS FOR PREPARING | |
ECSP16086746A (en) | IMMUNOSUPPRESSOR FORMULATION | |
CU20130165A7 (en) | MODIFIED RELEASE OF 4-METHYL-3 - [[- 4- (3- PIRIDINIL) -2-PYRIMIDINYL] AMINO] -N-5- (4- METHYL-1H-IMIDAZOL-1- IL) -3- (TRIFLUOROMETIL) FENIL] SOLUBILIZED BENZAMIDE USING ORGANIC ACIDS | |
UA97982U (en) | DRESSING MEDICINE FOR TABLETS |